During times of turbulence and uncertainty in the markets, many investors turn to dividend-yielding stocks. These are often companies that have high free cash flows and reward shareholders with a high dividend payout.
Benzinga readers can review the latest analyst takes on their favorite stocks by visiting our Analyst Stock Ratings page. Traders can sort through Benzinga's extensive database of analyst ratings, including by analyst accuracy. Here's a look at the most recent high-yield dividend stock ratings from the most accurate Wall Street analysts, according to Benzinga's Analyst Stock Ratings.
Below are the ratings of the most accurate analysts for three high-yielding stocks in the consumer staples sector.
Altria Group, Inc. MO
- Dividend Yield: 8.08%
- Citigroup analyst Adam Spielman maintained a Neutral rating and cut the price target from $49.5 to $47 on April 17, 2023. This analyst has an accuracy rate of 63%.
- Stifel analyst Matthew Smith reinstated a Buy rating with a price target of $52 on April 14, 2023. This analyst has an accuracy rate of 69%.
- Recent News: Altria Group reported a first-quarter FY23 sales decline of 2.9% year-on-year to $5.7 billion
Medifast, Inc. MED
- Dividend Yield: 7.49%
- DA Davidson analyst Linda Bolton Weiser maintained a Neutral rating and cut the price target from $94 to $71 on May 2, 2023. This analyst has an accuracy rate of 68%.
- Jefferies analyst Stephanie Wissink downgraded the stock from Buy to Hold and cut the price target from $345 to $150 on Aug. 4, 2022. This analyst has an accuracy rate of 81%.
- Recent News: Medifast posted better-than-expected Q1 results.
Philip Morris International Inc. PM
- Dividend Yield: 5.30%
- Stifel analyst Matthew Smith reinstated a Buy rating with a price target from $114 on April 14, 2023. This analyst has an accuracy rate of 69%.
- Goldman Sachs analyst Bonnie Herzog upgraded the stock from Neutral to Buy and raised the price target from $95 to $120 on Jan. 25, 2023. This analyst has an accuracy rate of 73%.
- Recent News: Philip Morris reported mixed Q1 financial results and issued FY23 adjusted diluted EPS guidance below estimates.
Read More: Fear & Greed Index Moves To 'Neutral' Zone Ahead Of Fed Rate Decision
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.